{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:35:42Z","timestamp":1715596542318},"reference-count":34,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p>The prevalence of \"primary aldosteronism\" (PAL) cannot be precisely determined at this time, given 1) lack of a universally accepted definition, and 2) normotensive as well as normokalemic phases in the evolutionary development of a disease eventually characterized by hypertension and hypokalemia. The exception is fully genetically characterised forms such as glucocorticoid-suppressible hyperaldosteronism, the true prevalence of which could be proven today by universal screening using a single blood sample, but this is neither practical nor appropriate. Controversy has arisen regarding the rareness, or otherwise, of PAL because of 1) rediscovery in the last 12 years of the normokalemic phase described by Conn, 2) application of widely available methods for measurement of aldosterone and renin to \"screening\", 3) variable quality of these methods, and of their application, and 4) lack of the necessary \"diagnostic\", in addition to \"screening\", tests in some studies. PAL is significantly more common than previously thought, and a very important potentially curable form of hypertension. Early diagnosis and specific treatment avoids morbidity. The current focus on increased detection is essential, and will help to resolve the question of prevalence.<\/jats:p>","DOI":"10.1590\/s0004-27302004000500012","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T16:04:58Z","timestamp":1115913898000},"page":"666-673","source":"Crossref","is-referenced-by-count":11,"title":["Primary aldosteronism: actual epidemics or false alarm?"],"prefix":"10.1590","volume":"48","author":[{"given":"Richard D.","family":"Gordon","sequence":"first","affiliation":[{"name":"University of Queensland; Greenslopes Hospital,  Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Kaplan NM","year":"2004","journal-title":"J Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0263-6352","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.jhh.1001319","article-title":"Is there an epidemic of primary aldosteronism?","volume":"16","author":"Connell JMC","year":"2002","journal-title":"J Hum Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0950-9240","issn-type":"print"},{"key":"ref3","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954-1967","volume":"62","author":"Conn JW","year":"1968","journal-title":"Harvey Lect","ISSN":"http:\/\/id.crossref.org\/issn\/0073-0874","issn-type":"print"},{"key":"ref4","first-page":"6","article-title":"Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn JW","year":"1955","journal-title":"J Lab Clin Med","ISSN":"http:\/\/id.crossref.org\/issn\/0022-2143","issn-type":"print"},{"key":"ref5","first-page":"222","article-title":"Plasma renin activity in primary aldosteronism: Importance in differential diagnosis and in research of essential hypertension","volume":"190","author":"Conn JW","year":"1964","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref6","first-page":"100","article-title":"Normokalemic primary aldosteronism: a detectable cause of curable essential hypertension","volume":"193","author":"Conn JW","year":"1965","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12 percent incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon RD","year":"1993","journal-title":"Clin Exp Pharmacol Physiol","ISSN":"http:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon RD","year":"1994","journal-title":"Clin Exp Pharmacol Physiol","ISSN":"http:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary care population","volume":"353","author":"Lim PO","year":"1999","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim PO","year":"2000","journal-title":"J Hum Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0950-9240","issn-type":"print"},{"key":"ref11","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh KC","year":"2000","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref12","first-page":"394","article-title":"The aldosterone\/renin ratio as a screening test for primary aldosteronism","volume":"90","author":"Rayner BL","year":"2000","journal-title":"South African Med J"},{"key":"ref13","first-page":"1863","article-title":"Primary aldosteronism in essential hypertensives; prevalence, biochemical profile and molecular biology","volume":"85","author":"Fardella CE","year":"2000","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref14","series-title":"Internal Medicine","first-page":"2188","volume-title":"Disorders of the adrenal cortex","author":"Biglieri EG","year":"1991","edition":"3"},{"key":"ref15","series-title":"Clinical Hypertension","first-page":"389","author":"Kaplan NM","year":"1994","edition":"6"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0889-8529(05)70283-8","article-title":"Pheochromocytoma and primary aldosteronism: diagnostic approaches","volume":"26","author":"Young WF Jr","year":"1997","journal-title":"Endocrinol Metab Clin North Am","ISSN":"http:\/\/id.crossref.org\/issn\/0889-8529","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","article-title":"Incidence of primary aldosteronism in uncomplicated \"essential\" hypertension: A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria","volume":"205","author":"Fishman LM","year":"1968","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref18","first-page":"19","article-title":"Falsely high plasma potassium values in patients with hyperaldosteronism","volume":"2","author":"Brown JJ","year":"1970","journal-title":"Br Med J","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"ref19","series-title":"Textbook of Hypertension","first-page":"865","volume-title":"Primary aldosteronism and other forms of mineralocorticoid hypertension","author":"Gordon RD","year":"1994"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of more robust and reproducible methodology in screening for primary aldosteronism","volume":"22","author":"Gordon RD","year":"2004","journal-title":"J Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0263-6352","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.ten.0000139006.29471.9e","article-title":"The aldosterone-renin ratio in screening for primary aldosteronism","volume":"14","author":"Stowasser M","year":"2004","journal-title":"The Endocrinologist"},{"key":"ref22","first-page":"S103","article-title":"Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low renin essential hypertension","volume":"5","author":"Gordon RD","year":"1987","journal-title":"J Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0263-6352","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: Results in hypertensive patients","volume":"141","author":"Hiramatsu K","year":"1981","journal-title":"Arch Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1681.1985.tb02641.x","article-title":"Is aldosterone\/renin ratio useful to screen a hypertensive population for primary aldosteronism?","volume":"12","author":"Hamlet SM","year":"1985","journal-title":"Clin Exp Pharmacol Physiol","ISSN":"http:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero P","year":"2002","journal-title":"Hypertension","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications; plasma aldosterone-renin ratio","volume":"37","author":"Gallay BJ","year":"2001","journal-title":"Am J Kidney Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0272-6386","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0140-6736(92)93225-C","article-title":"Hypothesis. Primary aldosteronism: hypertension with a genetic basis","volume":"340","author":"Gordon RD","year":"1992","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon RD","year":"1991","journal-title":"Clin Exp Pharmacol Physiol","ISSN":"http:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"ref29","first-page":"S264","article-title":"Primary aldosteronism: implications of a new familial variety","volume":"9","author":"Stowasser M","year":"1991","journal-title":"J Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0263-6352","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11-beta-hydroxylase\/aldosterone-synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton RP","year":"1992","journal-title":"Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00268-001-0033-4","article-title":"Primary aldosteronism: are we diagnosing and operating on too few patients?","volume":"25","author":"Gordon RD","year":"2001","journal-title":"World J Surg","ISSN":"http:\/\/id.crossref.org\/issn\/0364-2313","issn-type":"print"},{"key":"ref32","first-page":"2149","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, following \"non-selective\" screening of hypertensives attending a recently established hypertension unit","volume":"21","author":"Stowasser M","year":"2003","journal-title":"J Hypertens","ISSN":"http:\/\/id.crossref.org\/issn\/0263-6352","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1043-2760(98)00058-7","article-title":"Familial forms broaden horizons for primary aldosteronism","volume":"9","author":"Gordon RD","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(03)00112-7","article-title":"Primary aldosteronism: from genesis to genetics","volume":"14","author":"Stowasser M","year":"2003","journal-title":"Trends Endocrinol Metab"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v48n5\/a12v48n5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T02:14:18Z","timestamp":1495678458000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302004000500012&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0004-27302004000500012"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302004000500012","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}